Your browser doesn't support javascript.
loading
Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging.
Pontecorvo, Michael J; Arora, Anupa K; Devine, Marybeth; Lu, Ming; Galante, Nick; Siderowf, Andrew; Devadanam, Catherine; Joshi, Abhinay D; Heun, Stephen L; Teske, Brian F; Truocchio, Stephen P; Krautkramer, Michael; Devous, Michael D; Mintun, Mark A.
Afiliación
  • Pontecorvo MJ; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA. pontecorvo@avidrp.com.
  • Arora AK; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Devine M; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Lu M; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Galante N; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Siderowf A; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Devadanam C; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Joshi AD; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Heun SL; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Teske BF; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Truocchio SP; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Krautkramer M; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Devous MD; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
  • Mintun MA; Avid Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly and Company), 3711 Market St, Philadelphia, PA, 19104, USA.
Eur J Nucl Med Mol Imaging ; 44(5): 825-837, 2017 May.
Article en En | MEDLINE | ID: mdl-28064343
ABSTRACT

PURPOSE:

This study examined the feasibility of using quantitation to augment interpretation of florbetapir PET amyloid imaging.

METHODS:

A total of 80 physician readers were trained on quantitation of florbetapir PET images and the principles for using quantitation to augment a visual read. On day 1, the readers completed a visual read of 96 scans (46 autopsy-verified and 50 from patients seeking a diagnosis). On day 2, 69 of the readers reinterpreted the 96 scans augmenting their interpretation with quantitation (VisQ method) using one of three commercial software packages. A subset of 11 readers reinterpreted all scans on day 2 based on a visual read only (VisVis control). For the autopsy-verified scans, the neuropathologist's modified CERAD plaque score was used as the truth standard for interpretation accuracy. Because an autopsy truth standard was not available for scans from patients seeking a diagnosis, the majority VisQ interpretation of the three readers with the best accuracy in interpreting autopsy-verified scans was used as the reference standard.

RESULTS:

Day 1 visual read accuracy was high for both the autopsy-verified scans (90%) and the scans from patients seeking a diagnosis (87.3%). Accuracy improved from the visual read to the VisQ read (from 90.1% to 93.1%, p < 0.0001). Importantly, access to quantitative information did not decrease interpretation accuracy of the above-average readers (>90% on day 1). Accuracy in interpreting the autopsy-verified scans also increased from the first to the second visual read (VisVis group). However, agreement with the reference standard (best readers) for scans from patients seeking a diagnosis did not improve with a second visual read, and in this cohort the VisQ group was significantly improved relative to the VisVis group (change 5.4% vs. -1.1%, p < 0.0001).

CONCLUSION:

These results indicate that augmentation of visual interpretation of florbetapir PET amyloid images with quantitative information obtained using commercially available software packages did not reduce the accuracy of readers who were already performing with above average accuracy on the visual read and may improve the accuracy and confidence of some readers in clinically relevant cases.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Interpretación de Imagen Asistida por Computador / Tomografía de Emisión de Positrones / Glicoles de Etileno / Compuestos de Anilina Límite: Aged / Female / Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Interpretación de Imagen Asistida por Computador / Tomografía de Emisión de Positrones / Glicoles de Etileno / Compuestos de Anilina Límite: Aged / Female / Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos